NCT07673809 — "A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy" trial site landscape

Public-registry site landscape for NCT07673809, “A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy”, a Duchenne Muscular Dystrophy study sponsored by AO GENERIUM. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07673809 (registry record)
Study title	A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy
Sponsor	AO GENERIUM
Condition(s)	Duchenne Muscular Dystrophy
Phase	PHASE1 / PHASE2
Listed sites	6
Site countries	Belarus, Russia

Patient-friendly overview of this study: eichor.com/study/NCT07673809.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07673809 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Duchenne Muscular Dystrophy trials

← Eichor home · All tracked trials · Duchenne Muscular Dystrophy studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →